Jeanne Lenzer is an award-winning independent medical investigative journalist and author whose work has also appeared in the BMJ, Journal of Family Practice, the New York Times, the Washington Post, and elsewhere.
Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.
The Food and Drug Administration has approved controversial drug treatments for Alzheimer’s disease amid excess deaths, questionable efficacy, and conflicts of interest between regulators, patient advocates, and Big Pharma.